Phase Ib Trial of Folate Binding Protein (FBP)-Derived Peptide Vaccines, E39 and an Attenuated Version, E39′: An Analysis of Safety and immune Response

In this randomized phase Ib trial, we tested combining the E39 peptide vaccine with a vaccine created from E39′, an attenuated version of E39. Patients with breast or ovarian cancer, who were disease-free after standard of care therapy, were enrolled and randomized to one of three arms. Arm EE recei...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Clin Immunol
Main Authors: Vreeland, Timothy J., Litton, Jennifer K., Qiao, Na, Philips, Anne V., Alatrash, Gheath, Hale, Diane F., Jackson, Doreen O., Peace, Kaitlin M., Greene, Julia M., Berry, John S, Clifton, Guy T., Peoples, George E
Formato: Artigo
Idioma:Inglês
Publicado em: 2018
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5988975/
https://ncbi.nlm.nih.gov/pubmed/29574039
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.clim.2018.03.010
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados